Vicore Pharma Holding AB (VCRE)
Vicore Pharma Holding AB (publ), a clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden. The company de...
- Open
- 11.315
- High
- 11.325
- Low
- 11.140
- Prev. Close
- 11.350
- Volume
- 4.03K
- Turnover
- 45.48K
- Avg Price
- 11.277
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 1.63%
- 52wk High
- 17.800
- Volume Ratio
- 1.38
- Turnover Ratio
- 0.02%
Vicore Pharma Holding AB Analyst Rating
View moreForecast & Rating
Aug 21, 2026Price forecast
$34.94213.62%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- StockTitan · 1 day ago, 05:20 PM
Vicore Pharma to Present at The Pareto Securities 17th Annual Healthcare Conference | VCRE Stock News
- Quartr · 2 days ago, 01:44 AM
VICO: Buloxibutid shows strong efficacy and safety for IPF, advancing in a pivotal global Phase 2b trial
- StockTitan · Aug 23 at 05:15 PM
Vicore Pharma to Present at the European Respiratory Society Congress 2026 | VCRE Stock News
- businessinsider · Aug 21 at 04:11 PM
Vicore Pharma Holding AB (publ) GAAP EPS of SEK -0.51, revenue of SEK 2.2M
- PUBT · Aug 21 at 01:07 AM
Vicore Pharma Q2 FY26 operating loss widens to SEK 150.1 million; loss per share deepens to SEK 0.51
- benzinga_article · Aug 17 at 07:05 AM
Evolution Metals & Technologies, Barfresh Food Group, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
